Literature DB >> 2567800

In-situ breast cancer: the EORTC consensus meeting.

J A van Dongen, I S Fentiman, J R Harris, R Holland, J L Peterse, B Salvadori, H J Stewart.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2567800     DOI： 10.1016/s0140-6736(89)90263-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

Review 1.  Management of ductal carcinoma in situ of the breast.

Authors:  N J Carty; C Carter; G T Royle; C D Johnson
Journal:  Ann R Coll Surg Engl       Date:  1995-05       Impact factor: 1.891

2.  Prospective comparison of stereotactic core biopsy and surgical excision as diagnostic procedures for breast cancer patients.

Authors:  M Morrow; L Venta; T Stinson; C Bennett
Journal:  Ann Surg       Date:  2001-04       Impact factor: 12.969

3.  Interpretation of the risk associated with the unexpected finding of lobular carcinoma in situ.

Authors:  S Zurrida; C Bartoli; V Galimberti; R Raselli; L Barletta
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

4.  Impact of the presence and quantity of ductal carcinoma in situ component on the outcome of invasive breast cancer.

Authors:  Carla Cedolini; Serena Bertozzi; Ambrogio P Londero; Luca Seriau; Michela Andretta; Diane Agakiza; Sandro Fongione; Alessandro Uzzau; Andrea Risaliti
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 5.  Management of in situ and minimally invasive breast carcinoma.

Authors:  E R Frykberg; K I Bland
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

6.  Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression.

Authors:  Mohammad Obaidul Hoque; Maria Prencipe; Maria Luana Poeta; Raffaela Barbano; Vanna Maria Valori; Massimiliano Copetti; Antonietta Pia Gallo; Mariana Brait; Evaristo Maiello; Adolfo Apicella; Raffaele Rossiello; Francesco Zito; Tommasi Stefania; Angelo Paradiso; Massimo Carella; Bruno Dallapiccola; Roberto Murgo; Illuminato Carosi; Michele Bisceglia; Vito Michele Fazio; David Sidransky; Paola Parrella
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-09-29       Impact factor: 4.254

7.  Metastatic potential of small and minimally invasive breast carcinomas.

Authors:  H P Sinn; A Oelmann; H W Anton; I J Diel
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

8.  Ductal carcinoma in situ is presumably not a metastatic disease: a reply to "Commentary: Wherein the authors attempt to minimize the confusion generated by their study 'Breast cancer mortality after a diagnosis of ductal carcinoma in situ' by several commentators who disagree with them and a few who don't: a qualitative study".

Authors:  Brett T Snodgrass
Journal:  Curr Oncol       Date:  2018-04-30       Impact factor: 3.677

9.  Nipple discharge: a sign of breast cancer?

Authors:  T Richards; A Hunt; S Courtney; H Umeh
Journal:  Ann R Coll Surg Engl       Date:  2007-03       Impact factor: 1.891

10.  Impact of an extensive in situ component on the presence of residual disease in screen detected breast cancer.

Authors:  I D Campbell; J M Theaker; G T Royle; R Coddington; R Carpenter; A Herbert; I Moore; C Rubin; I Taylor; P B Guyer
Journal:  J R Soc Med       Date:  1991-11       Impact factor: 18.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.